drugset / Trial / NCT00662441

Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

NCT00662441

Phase 4 Completed 102 enrolled Bayer GlaxoSmithKline · collab
Non-randomizedCrossoverOpen-labelTreatment

Summary

Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. An ideal treatment option should be effective and reliable, have minimal side effects, be simple to use and affordable. The purpose was the evaluation of efficacy and safety of 10 mg oral Vardenafil in Nigerian subjects with Erectile Dysfunction (ED).

Timeline

Start
2003-09
Primary completion
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule 10 mg Oral

Indications